Cancer Immunotherapy Market will be US$ 228.5 Billion by 2032
Global Cancer Immunotherapy Market was US$ 96.5 Billion in 2023 and will grow US$ 228.5 Billion by 2032, with a CAGR of 10.05% from 2024 to 2032. Some of the main drivers propelling the market include the rising number of cancer patients, encouraging government initiatives, and the widespread availability of health insurance.